OUR SERVICES

Drug

Repurposing

  • Genomic signature based drug repurposing analyses have typically focused on the identification of compounds that reverse or reinforce a set of differentially expressed genes.

 

 

  • Our team performs systems-scale analyses that define disease on the basis of the global architecture and connectivity structure of the underlying gene networks.

 

 

  • We identify novel drug repurposing candidates that are predicted to target global changes in gene network patterns.

PERTH
AUSTRALIA

Nick Bosco

nick.bosco@insigene.com

 

ARIZONA
UNITED STATES

© 2021 Insigene Ltd. Site developed by NFIC Services.